Cellular Milieu Imparts Distinct Pathological α-Synuclein Strains in α-Synucleinopathies
暂无分享,去创建一个
John L. Robinson | J. Trojanowski | K. Luk | Bin Zhang | V. Lee | D. Covell | Ronald J. Gathagan | R. M. Pitkin | Chao Peng | Modupe F. Olufemi | Anna M. Stieber | Coraima Medellin | Rose M. Pitkin | Kelvin C. Luk
[1] D. Dickson,et al. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[2] V. Lee,et al. Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies , 2017, The Journal of Biological Chemistry.
[3] John L. Robinson,et al. Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease , 2017, Neuropathology and applied neurobiology.
[4] John Q. Trojanowski,et al. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease , 2016, Alzheimer's & Dementia.
[5] D. Geschwind,et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism , 2015, Proceedings of the National Academy of Sciences.
[6] T. Südhof,et al. Propagation of prions causing synucleinopathies in cultured cells , 2015, Proceedings of the National Academy of Sciences.
[7] M. Giugliano,et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.
[8] K. Luk,et al. Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite–like aggregates , 2014, Nature Protocols.
[9] Murray Grossman,et al. A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank , 2014, Alzheimer's & Dementia.
[10] A. Lees,et al. Alpha-synuclein mRNA expression in oligodendrocytes in MSA , 2014, Glia.
[11] P. Brundin,et al. Alpha‐synuclein transfers from neurons to oligodendrocytes , 2014, Glia.
[12] Bin Zhang,et al. Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons , 2013, Cell.
[13] J. Trojanowski,et al. Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy , 2013, The Journal of Neuroscience.
[14] J. Trojanowski,et al. Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.
[15] John L. Robinson,et al. Neuropathologic substrates of Parkinson disease dementia , 2012, Annals of neurology.
[16] J. Golden,et al. Delayed Myelination in an Intrauterine Growth Retardation Model Is Mediated by Oxidative Stress Upregulating Bone Morphogenetic Protein 4 , 2012, Journal of neuropathology and experimental neurology.
[17] J. Trojanowski,et al. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice , 2012, The Journal of experimental medicine.
[18] Tapan P. Patel,et al. Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.
[19] V. Lee,et al. Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles* , 2011, The Journal of Biological Chemistry.
[20] I. Kimura,et al. Mutant WDR36 directly affects axon growth of retinal ganglion cells leading to progressive retinal degeneration in mice , 2010, Human molecular genetics.
[21] J. Trojanowski,et al. Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells , 2009, Proceedings of the National Academy of Sciences.
[22] E. Waxman,et al. Specificity and Regulation of Casein Kinase-Mediated Phosphorylation of &agr;-Synuclein , 2008, Journal of neuropathology and experimental neurology.
[23] R. Mandel,et al. The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson disease , 2008, Proceedings of the National Academy of Sciences.
[24] A. Young,et al. Absence of α-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia , 2005, Journal of Neural Transmission.
[25] J. Trojanowski,et al. Mouse Model of Multiple System Atrophy α-Synuclein Expression in Oligodendrocytes Causes Glial and Neuronal Degeneration , 2005, Neuron.
[26] R. Doms,et al. Secretion and Intracellular Generation of Truncated Aβ in β-Site Amyloid-β Precursor Protein-cleaving Enzyme Expressing Human Neurons* , 2003, The Journal of Biological Chemistry.
[27] J. Trojanowski,et al. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases , 2002, Annals of neurology.
[28] J. Trojanowski,et al. Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein , 2002, Neuron.
[29] E. Masliah,et al. α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.
[30] J Q Trojanowski,et al. A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.
[31] T. Montine,et al. Immunohistochemical and Biochemical Studies Demonstrate a Distinct Profile of α‐Synuclein Permutations in Multiple System Atrophy , 2000, Journal of neuropathology and experimental neurology.
[32] J. Trojanowski,et al. A panel of epitope‐specific antibodies detects protein domains distributed throughout human α‐synuclein in lewy bodies of Parkinson's disease , 2000, Journal of neuroscience research.
[33] Heidi Phillips,et al. Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.
[34] J. Trojanowski,et al. Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro * , 1999, The Journal of Biological Chemistry.
[35] J Q Trojanowski,et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.
[36] C. Richter-Landsberg,et al. Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells. , 1998, Experimental cell research.
[37] J Q Trojanowski,et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein , 1998, Annals of neurology.
[38] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[39] K. Seppi,et al. Multiple system atrophy. , 1994, International review of neurobiology.
[40] J. Trojanowski,et al. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro. , 2003, Biochemistry.
[41] J. Trojanowski,et al. Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein. , 1999, Neuroscience letters.